S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
International Paper's 5% Yield Offers Big Value
AI Stock Caught Trading Under Secret Name (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
Inflation is Why a Soft Landing is Bad for the Economy
AI Stock Caught Trading Under Secret Name (Ad)
EU announces plans to better protect its sensitive technologies from foreign snooping
A Growing 4% Dividend makes this a REIT to Shop For
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
International Paper's 5% Yield Offers Big Value
AI Stock Caught Trading Under Secret Name (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
Inflation is Why a Soft Landing is Bad for the Economy
AI Stock Caught Trading Under Secret Name (Ad)
EU announces plans to better protect its sensitive technologies from foreign snooping
A Growing 4% Dividend makes this a REIT to Shop For
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
International Paper's 5% Yield Offers Big Value
AI Stock Caught Trading Under Secret Name (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
Inflation is Why a Soft Landing is Bad for the Economy
AI Stock Caught Trading Under Secret Name (Ad)
EU announces plans to better protect its sensitive technologies from foreign snooping
A Growing 4% Dividend makes this a REIT to Shop For
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
International Paper's 5% Yield Offers Big Value
AI Stock Caught Trading Under Secret Name (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
AI Stock Caught Trading Under Secret Name (Ad)
Stock market today: World shares are mostly lower, tracking a rates-driven tumble on Wall Street
Inflation is Why a Soft Landing is Bad for the Economy
AI Stock Caught Trading Under Secret Name (Ad)
EU announces plans to better protect its sensitive technologies from foreign snooping
A Growing 4% Dividend makes this a REIT to Shop For
NASDAQ:GBIO

Generation Bio (GBIO) Stock Forecast, Price & News

$3.22
0.00 (0.00%)
(As of 10/3/2023 ET)
Compare
Today's Range
$3.16
▼
$3.32
50-Day Range
$3.21
▼
$5.36
52-Week Range
$3.15
▼
$7.35
Volume
88,842 shs
Average Volume
105,446 shs
Market Capitalization
$211.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.05
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Generation Bio MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
181.4% Upside
$9.05 Price Target
Short Interest
Bearish
4.21% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$15,362 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.05) to ($1.75) Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.27 out of 5 stars

Medical Sector

347th out of 966 stocks

Pharmaceutical Preparations Industry

140th out of 450 stocks

See Top Rated MarketRank™ Stocks Here

GBIO stock logo

About Generation Bio (NASDAQ:GBIO) Stock

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

GBIO Price History

GBIO Stock News Headlines

September 27, 2023 | markets.businessinsider.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Generation Bio (GBIO), Teladoc (TDOC) and Edwards Lifesciences (EW)
September 19, 2023 | finance.yahoo.com
Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit
October 4, 2023 | Behind the Markets (Ad)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
September 18, 2023 | finance.yahoo.com
We're Not Worried About Generation Bio's (NASDAQ:GBIO) Cash Burn
August 16, 2023 | msn.com
JP Morgan Maintains Generation Bio (GBIO) Neutral Recommendation
August 7, 2023 | msn.com
Generation Bio: Novel But Preclinical, Interesting But Without Data
August 7, 2023 | finanznachrichten.de
Generation Bio Co.: Generation Bio Reports Second Quarter 2023 Financial Results
August 3, 2023 | msn.com
Wedbush Reiterates Generation Bio (GBIO) Outperform Recommendation
October 4, 2023 | Oxford Club (Ad)
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
August 3, 2023 | finance.yahoo.com
Insider Buyers Lose US$80k As Generation Bio Sheds US$37m
August 3, 2023 | benzinga.com
Generation Bio Reports Second Quarter 2023 Financial Results
August 3, 2023 | markets.businessinsider.com
JMP Securities Sticks to Its Buy Rating for Generation Bio (GBIO)
August 3, 2023 | finance.yahoo.com
Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference
May 31, 2023 | finance.yahoo.com
Generation Bio to Present at the 2023 Jefferies Healthcare Conference
May 12, 2023 | markets.businessinsider.com
JMP Securities Keeps Their Buy Rating on Generation Bio (GBIO)
May 11, 2023 | finanznachrichten.de
Generation Bio Co.: Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
May 11, 2023 | markets.businessinsider.com
Where Generation Bio Stands With Analysts
May 11, 2023 | finance.yahoo.com
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates
May 10, 2023 | finance.yahoo.com
Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results
April 20, 2023 | msn.com
Needham Reiterates Generation Bio (GBIO) Buy Recommendation
April 19, 2023 | markets.businessinsider.com
The Latest Analyst Ratings for Generation Bio
April 11, 2023 | finance.yahoo.com
Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 10, 2023 | finance.yahoo.com
Here's Why We're Not At All Concerned With Generation Bio's (NASDAQ:GBIO) Cash Burn Situation
April 5, 2023 | finance.yahoo.com
Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer
March 24, 2023 | finance.yahoo.com
Moderna (MRNA) Inks Genetic Medicines Deal With Generation Bio
March 24, 2023 | benzinga.com
Why Generation Bio Shares Are Trading Higher Today
March 23, 2023 | markets.businessinsider.com
Needham Remains a Buy on Generation Bio (GBIO)
See More Headlines
Receive GBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Generation Bio and its competitors with MarketBeat's FREE daily newsletter.

GBIO Company Calendar

Last Earnings
8/02/2023
Today
10/03/2023
Next Earnings (Estimated)
11/02/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:GBIO
CUSIP
N/A
CIK
1733294
Web
generationbio.com
Phone
617-655-7500
Fax
N/A
Employees
150
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.05
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$2.23
Forecasted Upside/Downside
+181.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
6 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($2.08)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-136,640,000.00
Net Margins
N/A
Pretax Margin
-14,417.16%
Return on Equity
-45.12%
Return on Assets
-31.42%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.11
Quick Ratio
12.11

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.75 per share
Price / Book
0.68

Miscellaneous

Outstanding Shares
65,930,000
Free Float
52,216,000
Market Cap
$211.96 million
Optionable
Not Optionable
Beta
2.27
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Cameron Geoffrey McDonough M.D. (Age 53)
    Pres, CEO & Director
    Comp: $939.09k
  • Dr. Matthew Norkunas M.B.A. (Age 45)
    M.D., Chief Financial Officer
    Comp: $611.11k
  • Dr. Matthew Stanton Ph.D. (Age 50)
    Chief Scientific Officer
    Comp: $654.83k
  • Dr. Douglas Kerr M.B.A. (Age 56)
    M.D., Ph.D., Chief Medical Officer
    Comp: $659.1k
  • Dr. Tracy Zimmermann Ph.D. (Age 53)
    Chief Devel. Officer
    Comp: $622.74k
  • Dr. Mark D. Angelino Ph.D. (Age 50)
    Co-Founder
  • Dr. Robert Kotin Ph.D. (Age 67)
    Co-Founder
  • Ms. Antoinette Paone M.B.A. (Age 45)
    M.S., Chief Operating Officer
  • Ms. Yalonda Howze J.D. (Age 51)
    Chief Legal Officer & Sec.
  • Ms. Jasmin Tower
    Sr. VP of People & Operations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













GBIO Stock - Frequently Asked Questions

Should I buy or sell Generation Bio stock right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Generation Bio in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" GBIO shares.
View GBIO analyst ratings or view top-rated stocks.

What is Generation Bio's stock price forecast for 2023?

6 equities research analysts have issued 12 month price targets for Generation Bio's stock. Their GBIO share price forecasts range from $2.23 to $14.00. On average, they predict the company's share price to reach $9.05 in the next twelve months. This suggests a possible upside of 181.4% from the stock's current price.
View analysts price targets for GBIO or view top-rated stocks among Wall Street analysts.

How have GBIO shares performed in 2023?

Generation Bio's stock was trading at $3.93 on January 1st, 2023. Since then, GBIO shares have decreased by 18.2% and is now trading at $3.2150.
View the best growth stocks for 2023 here.

When is Generation Bio's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023.
View our GBIO earnings forecast.

How were Generation Bio's earnings last quarter?

Generation Bio Co. (NASDAQ:GBIO) released its quarterly earnings data on Wednesday, August, 2nd. The company reported ($0.47) earnings per share for the quarter, beating analysts' consensus estimates of ($0.49) by $0.02. The firm had revenue of $0.88 million for the quarter, compared to analyst estimates of $7.50 million.

What other stocks do shareholders of Generation Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Generation Bio investors own include DocuSign (DOCU), NVIDIA (NVDA), Overstock.com (OSTK), Boeing (BA), Pure Storage (PSTG), Mastercard (MA), QUALCOMM (QCOM), Riot Platforms (RIOT), Twilio (TWLO) and Enphase Energy (ENPH).

When did Generation Bio IPO?

(GBIO) raised $126 million in an IPO on Friday, June 12th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen acted as the underwriters for the IPO and Wedbush PacGrow was co-manager.

What is Generation Bio's stock symbol?

Generation Bio trades on the NASDAQ under the ticker symbol "GBIO."

How do I buy shares of Generation Bio?

Shares of GBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Generation Bio's stock price today?

One share of GBIO stock can currently be purchased for approximately $3.22.

How much money does Generation Bio make?

Generation Bio (NASDAQ:GBIO) has a market capitalization of $211.96 million. The company earns $-136,640,000.00 in net income (profit) each year or ($2.08) on an earnings per share basis.

How many employees does Generation Bio have?

The company employs 150 workers across the globe.

How can I contact Generation Bio?

Generation Bio's mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The official website for the company is generationbio.com. The company can be reached via phone at 617-655-7500 or via email at investors@generationbio.com.

This page (NASDAQ:GBIO) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -